Education
About Us
Working with TipRanks
Follow Us
Zivo Bioscience (ZIVO)
:ZIVO
ZIVO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.13 - $22.15
Previous CloseN/A
Volume326.00
Average Volume (3M)596.00
Market Cap
$67.67M
Enterprise ValueN/A
Total Cash (Recent Filing)$388.89K
Total Debt (Recent Filing)$18.15M
Price to Earnings (P/E)―
Beta0.50
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.35
Shares Outstanding3,759,213
10 Day Avg. Volume282
30 Day Avg. Volume596
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)408.87
Price to Cash Flow (P/CF)-17.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
---
Zivo Bioscience News
PremiumCompany Announcements
Zivo Bioscience Strengthens Board with New Director Appointment
PremiumCompany Announcements
Zivo Bioscience Enhances Equity Incentive Plans for Leadership
PremiumCompany Announcements
Zivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC Markets
---
Bulls Say, Bears Say
Bulls Say
Product DevelopmentPositive results from the avian flu study and plans for an additional trial are viewed favorably as it could expand ZIVO’s opportunities in poultry health.
Strategic PartnershipsZIVO is engaged in constructive discussions with two major global animal health companies regarding potential licensing agreements for ZIVO’s coccidiosis product.
Bears Say
Capital ChallengesThe ongoing challenges of raising capital as an unlisted security, with shares delisted from Nasdaq and trading on OTC Markets, is a concern.
Financial ConcernsZIVO had cash and equivalents of $159K and debt of $355K, and it is expected to burn an average of $1.7M per quarter through 2025, relying on private placements or high interest-rate loans for funding.
---
Ownership Overview
49.79% Insiders
―
Mutual Funds
0.01% Other Institutional Investors
50.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ZIVO FAQ
What was Zivo Bioscience ’s price range in the past 12 months?
Zivo Bioscience lowest stock price was $3.13 and its highest was $22.15 in the past 12 months.
What is Zivo Bioscience ’s market cap?
Zivo Bioscience ’s market cap is $67.67M.
When is Zivo Bioscience ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Zivo Bioscience ’s earnings last quarter?
Zivo Bioscience released its earnings results on Nov 13, 2023. The company reported -$1.05 earnings per share for the quarter, the consensus estimate of -$1.05 by $0.
Is Zivo Bioscience overvalued?
According to Wall Street analysts Zivo Bioscience ’s price is currently Overvalued.
Does Zivo Bioscience pay dividends?
Zivo Bioscience does not currently pay dividends.
What is Zivo Bioscience ’s EPS estimate?
Zivo Bioscience ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zivo Bioscience have?
Zivo Bioscience has 3,759,213 shares outstanding.
What happened to Zivo Bioscience ’s price movement after its last earnings report?
Zivo Bioscience reported an EPS of -$1.05 in its last earnings report, expectations of -$1.05. Following the earnings report the stock price went down -0.112%.
Which hedge fund is a major shareholder of Zivo Bioscience ?
Currently, no hedge funds are holding shares in ZIVO
---
Zivo Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Insider Transactions
Bought Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
104.08%
12-Months-Change
Fundamentals
Return on Equity
657.30%
Trailing 12-Months
Asset Growth
195.68%
Trailing 12-Months
Company Description
Zivo Bioscience
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
---
ZIVO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---